The University of Texas M.D Anderson Cancer Center (MDACC) — Houston, Texas

Public research footprint of The University of Texas M.D Anderson Cancer Center (MDACC), compiled from the ClinicalTrials.gov public registry.

109

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Advanced Solid Tumor · Colorectal Cancer · Non-small Cell Lung Carcinoma

Recently updated registry entries

NCT06982521 — Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for… (Recruiting)
NCT06706076 — A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR… (Recruiting)
NCT07217301 — A Study Comparing TAK-928 With Docetaxel in Adults With Non-Small Cell Lung Cancer (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The University of Texas M.D Anderson Cancer Center (MDACC)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.